Zymergen Inc. Receivables Turnover Ratio (ZY), from the second quarter 2022 to the second quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Zymergen Inc.  (NASDAQ: ZY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Zymergen Accounts Receivables Turnover Ratio from the second quarter 2022 to the second quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Zymergen Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2022 to a ratio of 4.93, this represents a new company high. This is a clear indication for improving liquidity at Zymergen Inc.'s clients. Average receivable collection period, for the Zymergen in Jun 30 2022 quarter, has decreased to 74 days, compared to 75 days, in the Mar 31 2022 quarter.

If we take a look into Healthcare sector 441 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2922, from overall ranking in the first quarter 2022 at 3995.

What is Receivable Turnover Ratio?
What is Zymergen Inc. Selling?


What is Receivable Turnover Ratio?





ZY Receivables Turnover Ratio (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Receivable Change -42.64 % -41.72 % -26.11 % - -
Y / Y Revenue Change -55.26 % 28.27 % -48.54 % 27.24 % 384.13 %
Receivable Turnover Ratio (TTM) 4.93 4.89 4.12 4.52 5.09
ZY's Total Ranking # 2922 # 3995 # 4141 # 0 # 0
Accounts Receivable average collection period days 74 75 89 81 72
Seq. Receivable Change 54.06 % -22.24 % 17.52 % -59.26 % 56.56 %
Seq. Revenue Change -45.02 % 57.65 % -25.55 % -30.66 % 57.62 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 26
Healthcare Sector # 442
Overall Market # 2922

Receivable Turnover Ratio Statistics
High Average Low
4.93 4.39 3.63
(Jun 30 2022)   (Mar 31 2021)






Financial Statements
Zymergen's Accounts Receivable $ 4 Millions Visit ZY's Balance sheet
Zymergen's Sales TTM $ 15 Millions Visit ZY's Income Statement
Sources of ZY's Revenues Visit ZY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ZY's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ZY's Growth Rates ZY's Roa ZY's Inventory Turnover Ratio ZY's Dividend Comparisons
ZY's Profitability Ratios ZY's Roi ZY's Asset Turnover Ratio ZY's Dividend Growth
ZY's Valuation Ratios ZY's Roe ZY's Financial Strength Ratios ZY's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2022 Receivable at quarter ending Jun 30 2022
Protalix Biotherapeutics inc   10.73 $ 45.441  Millions$ 4.233  Millions
Lensar Inc   10.70 $ 36.872  Millions$ 3.445  Millions
Precipio inc   10.70 $ 9.487  Millions$ 0.887  Millions
Nascent Biotech Inc   10.67 $ 2.000  Millions$ 0.188  Millions
Cyclerion Therapeutics Inc   10.66 $ 1.897  Millions$ 0.178  Millions
U s Stem Cell Inc   10.56 $ 0.129  Millions$ 0.012  Millions
Cartesian Therapeutics Inc   10.55 $ 127.636  Millions$ 12.096  Millions
Caremax Inc   10.55 $ 532.125  Millions$ 50.459  Millions
Procyon Corporation  10.50 $ 4.842  Millions$ 0.461  Millions
Reflect Scientific Inc  10.50 $ 2.854  Millions$ 0.272  Millions
Strata Skin Sciences Inc  10.49 $ 32.914  Millions$ 3.136  Millions
Option Care Health Inc   10.45 $ 3,715.735  Millions$ 355.737  Millions
Marinus Pharmaceuticals Inc   10.43 $ 27.610  Millions$ 2.648  Millions
Surmodics Inc   10.42 $ 97.934  Millions$ 9.400  Millions
Scienture Holdings Inc   10.32 $ 10.445  Millions$ 1.012  Millions
Allied Healthcare Products inc   10.32 $ 27.047  Millions$ 2.622  Millions
Nrc Health  10.29 $ 151.798  Millions$ 14.753  Millions
Quanterix Corporation  10.24 $ 111.028  Millions$ 10.841  Millions
Cormedix Inc   10.21 $ 0.123  Millions$ 0.012  Millions
International Stem Cell Corporation  10.05 $ 7.732  Millions$ 0.769  Millions
Cytokinetics Incorporated  9.99 $ 151.153  Millions$ 15.123  Millions
Sanara Medtech Inc   9.97 $ 30.339  Millions$ 3.043  Millions
Utah Medical Products Inc  9.93 $ 51.237  Millions$ 5.161  Millions
Enzo Biochem Inc  9.92 $ 107.071  Millions$ 10.793  Millions
Vivos Therapeutics Inc   9.82 $ 16.768  Millions$ 1.707  Millions
Sunlink Health Systems Inc   9.81 $ 45.086  Millions$ 4.595  Millions
Milestone Scientific Inc   9.79 $ 9.304  Millions$ 0.950  Millions
Anika Therapeutics Inc   9.76 $ 151.707  Millions$ 15.549  Millions
Asensus Surgical Inc   9.69 $ 7.107  Millions$ 0.733  Millions
Cen Biotech Inc  9.66 $ 1.510  Millions$ 0.156  Millions

Date modified: 2026-10-07T00:41:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.